Clearance study for the estimation of glomerular filtration of Cd following the intravenous bolus of CdCl2 and Cd-saturated metallothionein-II in rats

Biol Pharm Bull. 1994 Apr;17(4):557-8. doi: 10.1248/bpb.17.557.

Abstract

A clearance study of Cd was carried out in rats that had received an intravenous bolus of CdCl2 or Cd-saturated metallothionein-II (Cd-MT-II) at 0.3 mg Cd/kg body weight. Urinary concentrations of Cd, and those corrected by the urine-plasma inulin ratio, were higher, by 2 or 3 orders of magnitude, for Cd-MT-II than for CdCl2. Fractional clearance of Cd was 0.0006 to 0.0029 for CdCl2, and 0.130 to 0.487 for Cd-MT-II. These findings denoted that the glomerular filtration of Cd was greater in the Cd-MT-II administration than in CdCl2 administration. This difference in the glomerular filtration of Cd gave a clear explanation for the greater nephrotoxic potential of Cd-MT-II. Also, our data revealed that when Cd was administered as Cd-MT-II, the concentration of Cd was 20 to 70 times higher at the end-point of the renal tubules than at its starting-point. This and the histopathological reports so far strongly suggest that the distally located tubules are highly resistant to intraluminal Cd.

MeSH terms

  • Animals
  • Cadmium / administration & dosage*
  • Cadmium / pharmacokinetics*
  • Cadmium / toxicity
  • Cadmium / urine
  • Cadmium Chloride
  • Chlorides / administration & dosage*
  • Chlorides / toxicity
  • Glomerular Filtration Rate
  • Injections, Intravenous
  • Kidney Tubules / metabolism*
  • Male
  • Metallothionein / administration & dosage*
  • Metallothionein / toxicity
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Chlorides
  • cadmium-binding protein
  • Cadmium
  • Metallothionein
  • Cadmium Chloride